Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728755 | SCV000856368 | uncertain significance | not provided | 2017-08-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477686 | SCV002778030 | uncertain significance | Alagille syndrome due to a NOTCH2 point mutation; Hajdu-Cheney syndrome | 2021-09-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002535091 | SCV003289712 | uncertain significance | Hajdu-Cheney syndrome | 2023-01-28 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NOTCH2 protein function. ClinVar contains an entry for this variant (Variation ID: 593653). This variant has not been reported in the literature in individuals affected with NOTCH2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 254 of the NOTCH2 protein (p.Gly254Trp). |
Gene |
RCV000728755 | SCV003927667 | uncertain significance | not provided | 2022-11-25 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004026953 | SCV004990213 | uncertain significance | Inborn genetic diseases | 2023-10-27 | criteria provided, single submitter | clinical testing | The c.760G>T (p.G254W) alteration is located in exon 5 (coding exon 5) of the NOTCH2 gene. This alteration results from a G to T substitution at nucleotide position 760, causing the glycine (G) at amino acid position 254 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |